Deferred Tax Assets, Valuation Allowance of Immuneering Corp from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Immuneering Corp quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • Immuneering Corp Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $73,378,421, a 24% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Immuneering Corp Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $73,378,421 +$14,383,714 +24% 31 Dec 2025 10-K 06 Mar 2026 2025 FY
Q4 2024 $58,994,707 +$15,719,798 +36% 31 Dec 2024 10-K 06 Mar 2026 2025 FY
Q4 2023 $43,274,909 +$11,234,961 +35% 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q4 2022 $32,039,948 +$14,362,049 +81% 31 Dec 2022 10-K 01 Mar 2024 2023 FY
Q4 2021 $17,677,899 +$10,550,451 +148% 31 Dec 2021 10-K 06 Mar 2023 2022 FY
Q4 2020 $7,127,448 31 Dec 2020 10-K 10 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.